IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells-Reference-Cited by-同舟云学术

IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells

Published:2022-06-01 Issue:1 Volume:13 Page:785-799
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tran Chau P.¹,Scurr Michelle¹,O’Connor Louise¹,Buzzelli Jon N.²,Ng Garrett Z.³,Chin Sharleen Chung Nien¹,Stamp Lincon A.⁴,Minamoto Toshinari⁵,Giraud Andrew S.¹²,Judd Louise M.²,Sutton Philip²³⁶,Menheniott Trevelyan R.¹²³⁶

Affiliation:

1. Tumour Immunology Group, Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

2. Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia

3. Mucosal Immunology Group, Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

4. Department of Anatomy and Physiology, The University of Melbourne, Victoria, Australia

5. Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

6. Co-senior authors

Publisher

Impact Journals, LLC

Subject

Oncology

Reference57 articles.

1. Smoldering and polarized inflammation in the initiation and promotion of malignant disease;Mantovani;Cancer Cell,2005

2. Helicobacter pylori infection and the development of gastric cancer;Schlemper;N Engl J Med,2001

3. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis;Graham;Gastroenterology,2016

4. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines;Kastelein;Immunity,2005

5. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor;Girard;Proc Natl Acad Sci U S A,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights;OncoTargets and Therapy;2023-08

2. Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?;Cells;2023-05-26

3. Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression;Journal of Advanced Research;2023-04

4. Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer;Frontiers in Immunology;2022-09-23